药易购：李燕飞拟协议转让5.23%公司股份

Core Viewpoint - The announcement reveals that the controlling shareholder and actual controller of the company, Li Yanfei, has signed a share transfer agreement with Gan Meng to transfer 5 million unrestricted circulating shares, representing 5.23% of the total share capital, at a price of 24 yuan per share, totaling 120 million yuan [1] Group 1 - The share transfer will reduce Li Yanfei and his concerted parties' shareholding from 43.98% to 38.75% [1] - Gan Meng will acquire a shareholding of 5.23% following the transfer [1] - The transaction does not trigger a mandatory tender offer, does not constitute a related party transaction, and will not result in a change of the company's controlling shareholder or actual controller [1]